Search research articles
Contact Us
Filters
Showing results (471-480 of 565) with videos related to
Page
of 57
Sort By:
European Journal of Heart Failure
|
January 18, 2020
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
Pierpaolo Pellicori, João Pedro Ferreira, Beatrice Mariottoni, et al.
Blood Pressure
|
July 15, 2025
Evaluation of race-free eGFR equations in individuals of different ethnicity
De-Wei An, Gontse G Mokwatsi, Dong-Yan Zhang, et al.
Cardiovascular Research
|
March 20, 2026
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension
Marek Rajzer, Wiktoria Wojciechowska, Andrzej Januszewicz, et al.
European Journal of Heart Failure
|
November 29, 2021
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
Susana Ravassa, Begoña López, João Pedro Ferreira, et al.
Blood Pressure
|
April 19, 2011
Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial
Augustine N Odili, Tom Richart, Lutgarde Thijs, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 6, 2024
Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial
Fang-Fei Wei, Pierpaolo Pellicori, João Pedro Ferreira, et al.
ESC Heart Failure
|
August 11, 2024
Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure
Fang-Fei Wei, Beatrice Mariottoni, De-Wei An, et al.
European Journal of Heart Failure
|
June 15, 2022
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial
Masatake Kobayashi, Nicolas Girerd, João Pedro Ferreira, et al.
BMC Genetics
|
October 3, 2015
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
Wen-Yi Yang, Thibault Petit, Lutgarde Thijs, et al.
Page
of 57
Search research articles
Search
Showing results (471-480 of 565) with videos related to
Sort By:
Page
of 57
European Journal of Heart Failure
|
January 18, 2020
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
Pierpaolo Pellicori, João Pedro Ferreira, Beatrice Mariottoni, et al.
Blood Pressure
|
July 15, 2025
Evaluation of race-free eGFR equations in individuals of different ethnicity
De-Wei An, Gontse G Mokwatsi, Dong-Yan Zhang, et al.
Cardiovascular Research
|
March 20, 2026
The impact of environmental pollution and climate change on hypertension: a position paper by the European Society of Hypertension (ESH) Working Group on Environment in Hypertension
Marek Rajzer, Wiktoria Wojciechowska, Andrzej Januszewicz, et al.
European Journal of Heart Failure
|
November 29, 2021
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
Susana Ravassa, Begoña López, João Pedro Ferreira, et al.
Blood Pressure
|
April 19, 2011
Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial
Augustine N Odili, Tom Richart, Lutgarde Thijs, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
September 6, 2024
Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial
Fang-Fei Wei, Pierpaolo Pellicori, João Pedro Ferreira, et al.
ESC Heart Failure
|
August 11, 2024
Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure
Fang-Fei Wei, Beatrice Mariottoni, De-Wei An, et al.
European Journal of Heart Failure
|
June 15, 2022
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial
Masatake Kobayashi, Nicolas Girerd, João Pedro Ferreira, et al.
BMC Genetics
|
October 3, 2015
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
Wen-Yi Yang, Thibault Petit, Lutgarde Thijs, et al.
Page
of 57